ReviewThe Journal of clinical investigation2019
Anti-VEGF therapy: higher potency and long-lasting antagonism are not necessarily better.
Ayumi Usui-Ouchi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
43 papers cite it
this paperpooled ittrialcites it